6533b821fe1ef96bd127ba4d

RESEARCH PRODUCT

Common Data Elements for Muscle Biopsy Reporting

Hans-hilmar GoebelYukiko K. HayashiStacy A. CossetteRachel AlvarezJahannaz DastgirCaroline SewryRaymond G. HoffmannAnne RutkowskiKe YanCarsten G. BönnemannMichael W. Lawlor

subject

0301 basic medicinemedicine.medical_specialtyMuscle biopsymedicine.diagnostic_testExtramuralbusiness.industryMEDLINEGeneral MedicineArticlePathology and Forensic Medicine03 medical and health sciencesMedical Laboratory Technology030104 developmental biology0302 clinical medicineMuscle diseaseBiopsyEmergency medicineEducational resourcesmedicinePhysical therapyMedical diagnosisbusiness030217 neurology & neurosurgery

description

Context There is no current standard among myopathologists for reporting muscle biopsy findings. The National Institute of Neurological Disorders and Stroke has recently launched a common data element (CDE) project to standardize neuromuscular data collected in clinical reports and to facilitate their use in research. Objective To develop a more-uniform, prospective reporting tool for muscle biopsies, incorporating the elements identified by the CDE project, in an effort to improve reporting and educational resources. Design The variation in current biopsy reporting practice was evaluated through a study of 51 muscle biopsy reports from self-reported diagnoses of genetically confirmed or undiagnosed muscle disease from the Congenital Muscle Disease International Registry. Two reviewers independently extracted data from deidentified reports and entered them into the revised CDE format to identify what was missing and whether or not information provided on the revised CDE report (complete/incomplete) could be successfully interpreted by a neuropathologist. Results Analysis of the data highlighted showed (1) inconsistent reporting of key clinical features from referring physicians, and (2) considerable variability in the reporting of pertinent positive and negative histologic findings by pathologists. Conclusions We propose a format for muscle-biopsy reporting that includes the elements in the CDE checklist and a brief narrative comment that interprets the data in support of a final interpretation. Such a format standardizes cataloging of pathologic findings across the spectrum of muscle diseases and serves emerging clinical care and research needs with the expansion of genetic-testing therapeutic trials.

https://doi.org/10.5858/arpa.2014-0453-oa